Heron Therapeutics Stock Price (NASDAQ:HRTX)

Add to My Stocks
$34.2 $0.4 (1.18%) HRTX stock closing price Sep 18, 2018 (Closing)
Prev Close* : $33.8
Market Cap:
$2.63B
Day Low: $33.2
52 Week Low: $14.40
Open: $33.9
Volume: -
Day High: $34.5
52 Week High: $42.90
Dividend:
0.00

Latest Stock Market News

Latest Articles

Heron Therapeutics News - From Partners

HRTX Stockcharts

View HRTX PE ratio, PS ratio stocks charts and compare with peers.
HRTX Chart
Note: Compare Heron Therapeutics stock price history with the index and industry peers.

Heron Therapeutics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
51.84
PB ratio (
price to book ratio
)
16.1

Heron Therapeutics Returns

ROE
(return on equity)
-128%

Heron Therapeutics Financial Ratios

Asset Turnover
0.2
Receivables Turnover
1.37
Debt to Equity
0.07
Dividend Yield
0%

HRTX Industry Peers

Company Price Change (%)
Ironwood Pharma (IRWD)17.290.2 (1.17%)
Aerie Pharma (AERI)56.550.4 (0.71%)
Merck (MRK)70.420 (0%)
Pacira Pharma (PCRX)47.851.6 (3.46%)
Insys Therapeutics (INSY)9.240.92 (11.06%)
Trevena (TRVN)1.650.03 (1.85%)
Cumberland Pharma (CPIX)5.620.02 (0.36%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

Heron Therapeutics Inc Stock News - Partner Headlines

Heron Therapeutics Financial Statements

income statement20172016201520142013
Net Sales or Revenues30.76M1.27M---
Net Income-197.48M-173.14M-97.59M-76.36M-55.28M
Total Operating Expense220.73M172.15M96.92M74.55M54.45M
View Heron Therapeutics income statement
balance sheet20172016201520142013
Total Assets234.3M67.48M137.84M76.68M75.93M
Total Liabilities103.17M88.73M19.73M13.62M6.99M
Shareholders Equity131.13M-21.25M118.11M63.06M68.94M
View Heron Therapeutics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-5.41M11.01M3.37M5.94M2.76M
Net Cash from (used by) Operating Activities-170.3M-134.09M-78.52M-60.28M-40.76M
Increase (Decrease) in Prop Plant And Equipment-2.47M-3.13M-0.84M-1.43M-1.68M
View Heron Therapeutics cash flow statement

Heron Therapeutics Stock Message Board

Heron Therapeutics stock gained 1.18%, and the last close price as of Sep 18, 2018 is $34.2 for HRTX stock. Heron Therapeutics market capitalization is $2.63B and it represents the total market value of HRTX stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Heron Therapeutics stock analysis.

For recognizing and analyzing the real performance of Heron Therapeutics stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 1,001,981 shares were traded with a closing stock price of $34.2 as of Sep 18, 2018, as can be seen from Heron Therapeutics stock quote. One can view Heron Therapeutics stock chart to follow the stock price trend. Heron Therapeutics paid 0.00 stock dividends to its shareholders during last quarter. One can observe stock price trends and check for volatility by checking Heron Therapeutics stock price history.